My guess is that the FDA, if we are to assume they

New Post Public Reply Private Reply Replies (3) Message Board
Respert24 craigakess #78438
702
My guess is that the FDA, if we are to assume they requested the raw uncut data (shimmy shimmy ya), would be able to analyze said data much faster than Amarex as they are the FDA and not a small company that apparently employs only former Kinko's and DMV employees.

So let's assume that the FDA is holding onto that sweet, sweet data as we speak. They've locked the doors to their office, untucked their shirts, and turned on private browsing for that down and dirty analysis everyone is craving. No dial up speeds here, kid. We're talking terabits, baby. Unghhhhhhhhhhhhhh.

Oh, lookie here.

Is that a life saved by mister Leron Leemab?

You bet your sweet ass it is.

More than one, at that. Now that's what I call a real humdinger of a drug.

Humdinger? Are you from the 50's?

Why yes, I am from the 50's. A time where people knew not to question their elders. Now get on up outta here with that jibber jabber. It's Leron time and AOL says I have exactly 13 more minutes of interwebs to get nasty with.

Hmmm, what's this I'm hearing about hitting pee values?

I didn't know it was that kind of party but I packed an extra set of clothes so let's save some lives with pee...

What's that?

It has nothing to do with urine? It's just how we calculate the probability that our null hypothesis is repeatable?

Well you done messed up now because I like nothing more than to get busy on that hypotenuse of yours.

Hm? That's not what either a hypothesis or a hypotenuse is?

Well than what are those?

They're a what now of a who dis?

Gurl, I think you're making this harder than it looks. Let me break it down for you.

It injects the Vyro in the body or it gets the mortality again.

I've completed my analysis. Get J-Cock on the phone. It's EUA time.


And that, my invisible internet friends, is what will happen tomorrow. To the TEE. Unless it happens the day after. Or next week. Or it doesn't involve any sort of confusion with urine whatsoever. I guess what I'm trying to say is...

There's nothing that has changed that should be making us think so negatively about the results. You can make a case for literally anything at this point and there would be at least a tiny bit of validity to it. I may have just consumed most of a bottle of wine and an almost 1lb filet mignon, but I can tell you unequivocally, and without remorse, that until we hear something from someone that gives us any sort of update there's just nothing any one of us truly knows about where we stand and what the data actually looks like.

In the immortal words of an obscure rap group called The Afros, "Don't get mad, get Glad. Heavy weight trash bags. You never see them tear."

#TechnicalAnalysis #BollingerBands #FibonacciRetrace

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Wolfbox K7 Pro: Night Driving's New Guardian

Updated Category News Views 99

Driving Under the Stars with the K7 Pro Let's be real here, night driving can give anyone a touch of the heebie-jeebies. Crunch time on the road when the lights dim and the stakes rise. Enter the Wolfbox K7 Pro, tailormade for these nocturnal journeys. This dash cam's no slouch—it packs a punch with true-blue 4K recording front and back. We're talking sharp images, even...

Continue Reading
Maple Leaf Foods' Q3 Results: Growth Amidst Inflation

Updated Category News Views 35

Navigating Inflationary Waters: A Maple Leaf Foods Update Seeing Maple Leaf Foods (TSX: MFI) push through a tough inflationary landscape with a 15.4% rise in EBITDA would make any seasoned investor nod in respect. They've gone from last year's $111.7 million to a hefty $129 million in Q3 2026. What's more, their EBITDA margin climbed to 12.5%, up 140 basis points from...

Continue Reading
Grant Davis Joins Assembly Health as CXO

Updated Category News Views 53

Shuffling Pieces in Healthcare Management Change is constant in healthcare management, folks, and it's all about finding the right puzzle pieces. That's what Assembly Health has done by welcoming Grant Davis as their new Chief Experience Officer (CXO). Yeah, you heard me right. It's not a CEO or a CFO, but the CXO role that's under the spotlight this time around, aiming...

Continue Reading
Tarte's Record-Breaking Collab: 60 Seconds to Sellout

Updated Category News Views 82

When Makeup Meets Pajamas: The Perfect Storm Picture this: a makeup brand and a lifestyle label dreaming up a collaboration that sends consumers into a full-blown frenzy. In a whirlwind that lasted just 60 seconds, tarte's latest partnership with Roller Rabbit blazed through stock, cementing its place as a record-breaking phenomenon. Maureen Kelly, tarte’s intrepid CEO,...

Continue Reading
Are BWIN, LFCR, PCRX Shareholder Deals Fair?

Updated Category News Views 113

What's Really Going On with BWIN, LFCR, and PCRX? Everyone talks about when there's smoke, there's fire. But in this case, it’s hard not to wonder if we're standing knee-deep in burning embers, or just a dusty old campfire. Halper Sadeh LLC is ringing the alarm bells for Baldwin Group, Lifecore Biomedical, and Pacira BioSciences, the trio tagged under NASDAQ: BWIN,...

Continue Reading
Illinois House Democrats Surge with Historic Gaines

Updated Category News Views 62

Turning the Election Tide in Illinois Damn, if you're not paying attention to what's shaking in Illinois, it's time to listen up. The Democrats under Speaker Emanuel "Chris" Welch are strutting their stuff, leaving an indelible mark on the political landscape. An eye-popping $35 million in campaign dough was raised, safeguarding every Democratic incumbent and managing to...

Continue Reading
UP Fintech Faces Major Class Action Amid Chinese Regulatory Hurdles

Updated Category News Views 110

Legal Battles Loom Over UP Fintech UP Fintech Holding Limited, trading under NASDAQ: TIGR, is knee-deep in legal mire, thanks to a hefty class action lawsuit. Levi & Korsinsky rings the legal bells for shareholders who grabbed TIGR securities from April 22, 2024, to June 2, 2026. The heat is on—a December 28, 2026 deadline for lead plaintiff spot beckons. Dust off those...

Continue Reading
Mazu Forum: Bridging Cultures and Marine Safety

Updated Category News Views 93

The 11th Global Mazu Culture Forum kicked off on November 1 in Putian City, Fujian Province—smack dab on the historical Meizhou Island. This ain’t just another talk-fest; it's a melting pot of ideas and achievements packaged with cultural flair and some serious tech muscle. Nestled in China's southeast, Meizhou Island serves as the heartland for Mazu culture, a beacon...

Continue Reading
Gildan Faces Fraud Lawsuit: Investors Can Lead Case

Updated Category News Views 63

Everyone's been dreaming about jackpot profits, huh? Well, for those holding onto Gildan Activewear Inc. (NYSE: GIL) shares, that bubble just popped. We're staring at a class-action lawsuit for securities fraud, accusing the company of cooking the books. Time for Wall Street's soap opera, folks. Understanding the Allegations Let's get to the grit. According to the lawsuit...

Continue Reading
Salomon Trail Week: International Bonding Over Trails

Updated Category News Views 86

A Weeklong Trail Adventure There's nothing quite like shaking off the cobwebs with a splash of mountain air mixed with a dash of raw athleticism. Salomon Trail Week wrapped up over in Linhai, China, marking yet another notch in the belt of trail running culture. This wasn't just a mere stampede over scenic trails but a full-on celebration of the global and Chinese trail...

Continue Reading
: Revenue Hits $100M - Continue Reading" aria-label="Continue reading: Fractal Sees Explosive Q2 Gain: Revenue Hits $100M"> Continue Reading